20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Zomedica Corp (NASDAQ:ZOM) shares are trading lower by 13.9% to $0.32 Tuesday morning after the company reported second-quarter earnings results.
What Happened?
Zomedica reported quarterly losses of 1 cent per share. The company also reported $4.20 million in sales this quarter. This is a marked increase from sales of $15,690 in the same period last year.
Larry Heaton, Zomedica's Chief Executive Officer, commented: "The second quarter of 2022 was an exciting one for Zomedica as we both grew revenue organically and also executed on our acquisition strategy. We were pleased with our revenue growth to $4.2 million which reflects a 51% increase on a pro-forma basis, over the combined revenue of Zomedica and PulseVet as a standalone company of $2.8 million in the second quarter of last year.
See Also: Here's How Much You'd Have Now If You Invested $1,000 In Bitcoin, Ethereum And Dogecoin 5 Years Ago
According to data from Benzinga Pro, Zomedica has a 52-week high of $0.80 and a 52-week low of $0.18.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!